Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW February 2006

Volume 15
Issue Number 2
February 2006
ISSN 10593802

AMN107 Shows Potent Activity in Leukemia Resistant to Imatinib

The second-generation tyrosine kinase inhibitor AMN107 has significant activity in patients with advanced imatinib-resistant chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia.
Go to Previous Page

Source & Additional Reading

H. M. Kantarjian, 47th Annual Meeting of the American Society of Hematology

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW February 2006

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW February 2006